Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000620609 | SCV000737451 | likely benign | Cardiovascular phenotype | 2015-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001000063 | SCV000883384 | benign | Long QT syndrome 11 | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001517667 | SCV001726210 | benign | Long QT syndrome | 2022-10-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755803 | SCV001794532 | likely benign | not provided | 2019-11-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001000063 | SCV002524826 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing |